Welcome!

News Feed Item

Global Neurotechnology Industry 2014 Report: Company Profiles and Pipeline Analysis from Over 500 Companies and 20 Illnesses

DUBLIN, IRELAND -- (Marketwired) -- 08/15/14 -- Research and Markets (http://www.researchandmarkets.com/research/s7qvsb/the) has announced the addition of a new report "Neurotech Industry 2014 Report" to their offering.

Now in its 10th year, The Neurotechnology Industry 2014 Report is an expanded and updated 650 page report of brain and nervous system markets and treatments. It is the only publication to provide a comprehensive pipeline and market analysis to help investors, companies and entrepreneurs easily identify opportunities, understand the competitive landscape, determine risks and understand the dynamics of rapidly changing CNS markets.

The report includes detailed information on products in development globally for over 20 indications at 800 companies including Alzheimer's, addiction, ALS, anxiety, depressive disorders, epilepsy, migraine, mild cognitive impairment, Huntington's, multiple sclerosis, obesity, pain, Parkinson's, schizophrenia, age-related macular degeneration, sensory disorders, sleep disorders, traumatic brain injury and stroke.

Report Highlights:


--  More than 500 profiles of public and private neurotech companies
    including drugs, devices and diagnostics
--  Pipelines and market analysis for 20 brain and nervous system illnesses
    including: addiction, Alzheimer's disease, anxiety, attention disorders,
    depression, epilepsy, hearing loss, insomnia, mild cognitive impairment,
    migraine, multiple sclerosis, obesity, pain, Parkinson's disease,
    retinal disorders, schizophrenia, stroke, and traumatic brain injury
--  Top neurotech investors, venture capital firms, and venture capital
    trends (1999-Q12014)
--  Neurotech IPOs (2004-Q12014), M&A (2004-Q12014), Partnering and
    Licensing deals (2005-Q12014) and public neurotech stock performance
--  Analysis of biological basis, current treatment options, and emerging
    therapeutic strategies
--  Analysis of compounds, cell therapies and devices in clinical trials
    (and abandoned) by company, mechanism of action and stage of development
    for each indication
--  Global and US market size, worldwide revenues for each indication
--  Extensive discussion of specific technological, demographic, regulatory
    and intellectual property trends

Key Topics Covered:

1: Executive Summary


--  The Brain Industry Revealed
--  Investment Risks and Opportunities

Key Industry Facts and Findings

2: Trends and Drivers


--  Converging Technology Drivers
--  Demographic Drivers
--  Social Drivers
--  Economic Drivers
--  Research Funding
--  Intellectual Property Trends

Neurotech Merger and Acquisition Activity (2005-Q1,2014)

3: Neuropharmaceutical Sector


--  Neuropharmaceutical Sector Overview
--  Neuropharmaceutical Partnering and Licensing
--  Neurology Markets and Pipelines
--  Psychiatry Markets and Pipelines
--  Sensory Markets and Pipelines

4: Stem Cells and Neuroregeneration


--  Defining Stem Cell Markets and Players
--  Stem Cell Approaches
--  Markets and Treatments in Development

5: Neurodevice Sector


--  Neurodevice Sector Overview
--  Neuroprosthetic Devices
--  Neuromodulation Devices
--  Neurosurgical devices
--  Neurosoftware
--  Therapeutic NeuroGaming

6: Neurodiagnostics Sector


--  Neurodiagnostic Sector Overview
--  Neuroimaging Technologies
--  In Vitro Diagnostics
--  Neuroinformatics

7: Private Neurotechnology Investment


--  Venture Capital Investment Trends
--  Neurotech Venture Capital Investment

8: Public Neurotechnology Investment


--  Investing in Public Neurotech Companies
--  Neurotech Initial Public Offerings
--  NeuroInsights Neurotech Index

9: Neurotechnology Research Centers


--  Leading Neurotechnology Research Centers
--  Places to Watch

10: Leading Neurotechnology Regions


--  The Global Neurotech Economy
--  Nexus Ranking and Methodology
--  Established Neurotech Nexus
--  Emerging Neurotech Nexus
--  Nascent Neurotech Nexus
--  Conclusions and Policy Recommendations

11: Company Profiles


--  Neuropharmaceutical & Cell Therapy Companies: Private
--  Neuropharmaceutical & Cell Therapy Companies: Public
--  Neurodevice Companies: Private
--  Neurodevice Companies: Public
--  Neurodiagnostic Companies: Private
--  Neurodiagnostic Companies: Public

12: Index

For more information visit http://www.researchandmarkets.com/research/s7qvsb/the

Source: NeuroInsights

Sector: Pharmaceuticals

Over 400 of the Fortune 500 buy their research from Research and Markets. Some of our clients in the area of Pharmaceuticals include:


--  Pfizer, Inc.
--  Novartis International AG.
--  GlaxoSmithKline plc
--  Merck & Co., Inc.
--  Genentech Inc.
--  McKinsey & Company, Inc.
--  Novo Nordisk
--  IGEN Biotech Group AG
--  Sanofi S.A.
--  Allergan, Inc.
--  FORUM Pharmaceuticals Inc
--  Bio-Rad Laboratories
--  Bain & Company
--  Nestle Health Science
--  Pacira Pharmaceuticals, Inc
--  DBV Technologies SA
--  Chimerix, Inc.

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
Unsecured IoT devices were used to launch crippling DDOS attacks in October 2016, targeting services such as Twitter, Spotify, and GitHub. Subsequent testimony to Congress about potential attacks on office buildings, schools, and hospitals raised the possibility for the IoT to harm and even kill people. What should be done? Does the government need to intervene? This panel at @ThingExpo New York brings together leading IoT and security experts to discuss this very serious topic.
More and more brands have jumped on the IoT bandwagon. We have an excess of wearables – activity trackers, smartwatches, smart glasses and sneakers, and more that track seemingly endless datapoints. However, most consumers have no idea what “IoT” means. Creating more wearables that track data shouldn't be the aim of brands; delivering meaningful, tangible relevance to their users should be. We're in a period in which the IoT pendulum is still swinging. Initially, it swung toward "smart for smar...
CloudJumper, a Workspace as a Service (WaaS) platform innovator for agile business IT, has been recognized with the Customer Value Leadership Award for its nWorkSpace platform by Frost & Sullivan. The company was also featured in a new report(1) by the industry research firm titled, “Desktop-as-a-Service Buyer’s Guide, 2016,” which provides a comprehensive comparison of DaaS providers, including CloudJumper, Amazon, VMware, and Microsoft.
"Dice has been around for the last 20 years. We have been helping tech professionals find new jobs and career opportunities," explained Manish Dixit, VP of Product and Engineering at Dice, in this SYS-CON.tv interview at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
Complete Internet of Things (IoT) embedded device security is not just about the device but involves the entire product’s identity, data and control integrity, and services traversing the cloud. A device can no longer be looked at as an island; it is a part of a system. In fact, given the cross-domain interactions enabled by IoT it could be a part of many systems. Also, depending on where the device is deployed, for example, in the office building versus a factory floor or oil field, security ha...
"ReadyTalk is an audio and web video conferencing provider. We've really come to embrace WebRTC as the platform for our future of technology," explained Dan Cunningham, CTO of ReadyTalk, in this SYS-CON.tv interview at WebRTC Summit at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
"At ROHA we develop an app called Catcha. It was developed after we spent a year meeting with, talking to, interacting with senior citizens watching them use their smartphones and talking to them about how they use their smartphones so we could get to know their smartphone behavior," explained Dave Woods, Chief Innovation Officer at ROHA, in this SYS-CON.tv interview at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
Cloud Expo, Inc. has announced today that Andi Mann returns to 'DevOps at Cloud Expo 2017' as Conference Chair The @DevOpsSummit at Cloud Expo will take place on June 6-8, 2017, at the Javits Center in New York City, NY. "DevOps is set to be one of the most profound disruptions to hit IT in decades," said Andi Mann. "It is a natural extension of cloud computing, and I have seen both firsthand and in independent research the fantastic results DevOps delivers. So I am excited to help the great t...
Rapid innovation, changing business landscapes, and new IT demands force businesses to make changes quickly. In the eyes of many, containers are at the brink of becoming a pervasive technology in enterprise IT to accelerate application delivery. In this presentation, attendees learned about the: The transformation of IT to a DevOps, microservices, and container-based architecture What are containers and how DevOps practices can operate in a container-based environment A demonstration of how ...
SYS-CON Events announced today that Fusion, a leading provider of cloud services, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Fusion, a leading provider of integrated cloud solutions to small, medium and large businesses, is the industry’s single source for the cloud. Fusion’s advanced, proprietary cloud service platform enables the integration of leading edge solutions in the cloud, including clou...
Fact: storage performance problems have only gotten more complicated, as applications not only have become largely virtualized, but also have moved to cloud-based infrastructures. Storage performance in virtualized environments isn’t just about IOPS anymore. Instead, you need to guarantee performance for individual VMs, helping applications maintain performance as the number of VMs continues to go up in real time. In his session at Cloud Expo, Dhiraj Sehgal, Product and Marketing at Tintri, sha...
WebRTC is the future of browser-to-browser communications, and continues to make inroads into the traditional, difficult, plug-in web communications world. The 6th WebRTC Summit continues our tradition of delivering the latest and greatest presentations within the world of WebRTC. Topics include voice calling, video chat, P2P file sharing, and use cases that have already leveraged the power and convenience of WebRTC.
Without lifecycle traceability and visibility across the tool chain, stakeholders from Planning-to-Ops have limited insight and answers to who, what, when, why and how across the DevOps lifecycle. This impacts the ability to deliver high quality software at the needed velocity to drive positive business outcomes. In his general session at @DevOpsSummit at 19th Cloud Expo, Phil Hombledal, Solution Architect at CollabNet, discussed how customers are able to achieve a level of transparency that e...
"Venafi has a platform that allows you to manage, centralize and automate the complete life cycle of keys and certificates within the organization," explained Gina Osmond, Sr. Field Marketing Manager at Venafi, in this SYS-CON.tv interview at DevOps at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
The many IoT deployments around the world are busy integrating smart devices and sensors into their enterprise IT infrastructures. Yet all of this technology – and there are an amazing number of choices – is of no use without the software to gather, communicate, and analyze the new data flows. Without software, there is no IT. In this power panel at @ThingsExpo, moderated by Conference Chair Roger Strukhoff, Dave McCarthy, Director of Products at Bsquare Corporation; Alan Williamson, Principal...